Clinical Trial Update: Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy and safety of tegaserod versus placebo in women with dyspepsia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia

Drugs mentioned

• Tegaserod (Zelnorm) (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Dyspepsia | Phase 3 | Status: COMPLETED